The clinical efficacy and safety analysis of 52 clinical cases of advanced non-small cell lung cancer treated with anlotinib in the third-line
SHAN Binbin
LI Yuan
ZHAO Chang
Machine-generated Keywords：
Publication Date：2020-12-10
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 909-912 )